About Singular Genomics
Singular Genomics is a Healthcare company based in San Diego (United States) founded in 2016 by Eli Glezer, and was acquired by Deerfield in December 2024. Next-generation gene sequencing and multi-omics technologies are provided. The company has 169 employees. Singular Genomics offers products and services including G4X Platform and Sequencing Support Hub. Its focus areas include Life Sciences, Genomics, Genomics Services and Sequencing. Its legal entity is Singular Genomics Systems, Inc. Its competitors include PacBio, Omniome and Complete Genomics; 3 of its 3 listed competitors have raised funding.
Company details
Singular Genomics was founded in 2016 in San Diego, United States, within the biotechnology sector focused on genomics. Next-generation sequencing and multi-omics technologies are developed and offered through integrated solutions. The G4 solution targets next-generation sequencing applications, while the PX solution addresses single-cell analysis, spatial profiling, and proteomics needs. Operations emphasize innovative engines for diverse research and diagnostic uses in life sciences.
- Headquarters San Diego, United States
- Employees 169
- Founders Eli Glezer
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website singulargenomics.com
- Social LinkedIn X
- Acquired by Casdin Capital (Aug 2021)
- Legal Name Singular Genomics Systems, Inc.
- Annual Revenue$2.91 M (USD)281as on Dec 31, 2023
- Net Profit-$94.82 M (USD)-4as on Dec 31, 2023
- EBITDA-$102.8 M (USD)-10as on Dec 31, 2023
- InvestorsCasdin Capital
& 1 more
- Employee Count169
- Acquired by
Products & Services of Singular Genomics
Singular Genomics offers a comprehensive portfolio of products and services, including G4X Platform and Sequencing Support Hub.
High-throughput system for in situ multiomics analysis of biological samples.
Resources for users of G4X platform in genomics research.
Investors in Singular Genomics
Singular Genomics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Casdin Capital and Deerfield.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investing in Life Sciences sectors like Healthcare and Biotechnology. | casdincapital.com | |||
Healthcare ecosystem is supported through investment and innovation by Deerfield. | deerfield.com | New York, United States |
Investor details for Singular Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Singular Genomics
52 people are tracked at Singular Genomics (14 in leadership, 9 in board & advisors, 29 in team); the tracked headcount is 169.
| Name | Role | Group |
|---|---|---|
Eli Glezer | Co-Founder & CSO | Leadership |
Vincent Brancaccio | Head, Human Resources | Leadership |
Jyotsna Ghai | COO | Leadership |
Mark Lane | Sr. Director, Field Services | Leadership |
Timothy Looney | Senior Director, Immunology And Bioinformatics | Leadership |
Abrehet Abdu | Senior Director Of Biochemistry | Leadership |
Shawn Carr | Vice President Of Manufacturing And Process Development | Leadership |
Jordan Williams | Associate Director, Field Applications Science | Leadership |
Darius Fugere | Senior Vice President, Commercial | Leadership |
Martín Fabani | Vice President, Sequencing Applications | Leadership |
Alena Harper | Associate Director, Human Resources | Leadership |
Daan Witters | Sr. Vice President, Research & Development | Leadership |
Josh Phelps | Sr. Director Of Facility Operations | Leadership |
Brandon Chimits | Associate Director, Process Engineering | Leadership |
David Ledbetter | Advisor | Board & advisors |
Daniel Shoemaker | Advisor | Board & advisors |
Larry Fong | Advisor | Board & advisors |
Elaine Mardis | Advisor | Board & advisors |
Jason Ryan | Director | Board & advisors |
Kim Kamdar | Director | Board & advisors |
32 more people are available in the full profile.
Complete people profiles for Singular Genomics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Singular Genomics
4 dated milestones of Singular Genomics across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Singular Genomics is founded.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Casdin Capital.
- Exit Acquired by Deerfield.
Competitors of Singular Genomics
Singular Genomics has 3 listed competitors in our database, 3 of them funded. They include PacBio, Omniome and Complete Genomics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pacb.com | 2004 | Menlo Park, United States | $395M | 649 | Instrument systems and software for single-molecule real-time sequencing are developed. | |
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| completegenomics.com | 2006 | San Jose, United States | $124.99M | 70 | DNA sequencing platform for human genome analysis is developed. |
Detailed competitors of Singular Genomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Singular Genomics
The website of Singular Genomics (singulargenomics.com) receives about 3.2K visits a month.
- Monthly visits3.2K
▼ 35.5% vs previous month
Websites whose visitors overlap most with Singular Genomics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| debutbiotech.com | 100% | 4.7K | #4,161,598 | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Singular Genomics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Singular Genomics
Complete news archive for Singular Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Singular Genomics
Singular Genomics was founded in 2016.
Singular Genomics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Singular Genomics has 169 employees.
Annual revenue of Singular Genomics is $2.91M as on Dec 31, 2023.
Singular Genomics was founded in 2016 in San Diego, United States, within the biotechnology sector focused on genomics. Next-generation sequencing and multi-omics technologies are developed and offered through integrated solutions. The G4 solution targets next-generation sequencing applications, while the PX solution addresses single-cell analysis, spatial profiling, and proteomics needs. Operations emphasize innovative engines for diverse research and diagnostic uses in life sciences.
Singular Genomics's top competitors include PacBio, Complete Genomics and Omniome.
Singular Genomics offers G4X Platform and Sequencing Support Hub.
Singular Genomics has 2 investors. Key investors include Casdin Capital, and Deerfield.
Singular Genomics operates through Singular Genomics Systems, Inc..
Yes. Singular Genomics was acquired by Casdin Capital in August 2021.